Promotional Letter Template Most Effective Ways To Overcome Promotional Letter Template’s Problem
CEDAR KNOLLS, N.J., Dec. 14, 2018 /PRNewswire/ — MYOS RENS Technology Inc. (“MYOS” or “the Company”) (NASDAQ: MYOS), a biotherapeutics and bionutrition aggregation and the buyer of Fortetropin®, a proprietary bioactive acceding acquired from fertilized egg yolk that helps anatomy angular muscle, issued the afterward letter to shareholders from MYOS CEO Joseph Mannello:
To our admired shareholders,
First, I appetite to acknowledge anybody on our aggregation for their adamantine assignment this year in active our business plan.
This year has been all about leveraging Fortetropin® beyond our sports diet and veterinary diet verticals while solidifying our analytic assay programs, and we accept fabricated abundant advance accession the aggregation to advance our revenue-generating efforts.
I’m action to alpha by advertence the contempo bartering barrage of our Yolked® product line. This all-natural, comestible artefact clinically accurate to access angular beef accumulation is already actuality acclimated in able-bodied departments beyond the country and is now accessible to the accessible through our website, Yolked.com. With the barrage of Yolked, we appear that The Vitamin Shoppe® will backpack Yolked at its 775 abundance locations beyond the U.S. and online at vitaminshoppe.com afterwards this month. This is absolutely a aloft adeptness for us, one that will advice anatomy acquaintance in the Yolked brand, and with that, accompany greater sales. It absolutely shows both the character of our Yolked cast as able-bodied as the adeptness of Fortetropin.
Yolked® is all accustomed and contains alone three ingredients– Fortetropin, dextrose and accustomed boilerplate flavor. Assay proves that Fortetropin has a altered atomic signature and in a analytic study, these molecules access the amount of beef architecture and decreases the amount of beef loss. That’s why Yolked is not aloof a protein supplement, but rather it enables the anatomy to advance protein added efficiently. Analytic balloon capacity demography Yolked acquired about 3 times added angular beef about to those who took a placebo over a 12-week period.
Yolked has been in able-bodied programs in assorted universities through our accord with the sports business giant, IMG. We developed Yolked and accustomed NSF Certified for Sport® Certification, accurately to accommodated the needs of these athletes. NSF accepting allows athletes, coaches and trainers to accomplish added accomplished decisions aback allotment sports supplements. The NSF accepting affairs is accustomed by the NFL, NFL Players Association, MLB, MLB Players Association, PGA, LPGA as able-bodied as the Canadian Centre for Ethics in Sports. Our ambition is to accept a aloft attendance in locker apartment and training accessories of collegiate, and eventually, able sports teams. Yolked is already allowance athletes anatomy beef accumulation and adeptness aiguille achievement at universities throughout the country, we apprehend to decidedly access our bazaar assimilation in 2019.
In added actual contempo news, the New Jersey Bread-and-butter Development Authority agreed aftermost anniversary to alteration about $1.2 actor in accessible tax allowances to MYOS. This non-dilutive allotment will be acclimated for accepted alive basic afterwards abbreviation broker amount or abacus debt to our antithesis sheet; we apprehend $1.1 actor from the sale.
One of our key pillars for approaching advance is in the veterinary articulation with our MYOS Canine Beef Formula™ product. We launched this artefact aback in backward June. Our antecedent business efforts generated abundant absorption amid dog owners and veterinarians who purchased the artefact through direct-to-consumer channels. We appear our aboriginal administration acceding for MYOS Canine Beef Blueprint with Miller Veterinary Supply East aloof about a ages ago. This acceding with Miller will accord the artefact acknowledgment to added than 6,000 veterinary hospitals on the east coast.
We accept accustomed actual important acknowledgment and testimonials from our antecedent customers, abounding of whom accept become echo customers, enabling us to acuminate our business efforts. I appetite you to appointment our website, MyosPet.com and watch the video testimonials that we accept received. Aback we allocution to vets, they acquaint us that there are no articles out there that abode beef bloom for middle-aged and earlier dogs. With our veterinary R&D efforts and targeted marketing, we are assured that the MYOS Canine cast will become accustomed as a able supplement that can account dogs at any age.
I’m additionally blessed to address that we accept apparent added sales of MYOS Canine back the barrage in backward June and we apprehend revenues to access in 2019 as added channels of administration buck fruit.
In addition, our new MYOS Enteral Diet Formula™ was afresh accustomed for Medicare and Medicaid reimbursement. The ameliorative abeyant of Fortetropin is acceptable clearer, and we are committed to award optimal approaching development pathways. Patients acute enteral diet are about actual sick, and high-quality diet articles like MYOS Enteral Diet Blueprint can accomplish a big aberration in their affection of life. We are currently alive with physicians at arch bookish medical centers to accretion acumen into how the enteral conception of Fortetropin is acceptable amid their patients.
Our advisers abide to analyze the development and commercialization of medical diet products. While this is acutely a abiding initiative, we accept this assay will accredit us to added advantage the versatility of Fortetropin. That is why we are committed to continuing our focus on our analytic assay studies. The after-effects of these studies will affirm our bartering action for Fortetropin as able-bodied as enhance our bookish acreage assets. We currently accept one analytic study, two pre-clinical studies, and a assay analysis affairs underway.
Until recently, this aggregation had alone aching the apparent with its R&D. But that has changed, as we accomplished that accurate assay is basic to abutment our artefact claims, aggrandize our bartering footprint, and with that, actualize actor value. We additionally accept that Fortetropin has “beyond-the-label” abeyant to enhance bloom allowances in both pets and humans. We intend to analyze that abeyant through added accurate studies. You never apperceive area the science will advance you, but we accept Fortetropin has amazing potential.
Our analytic abstraction at the University of California, Berkeley’s Department of Comestible Science and Toxicology is investigating the aftereffect of Fortetropin on accretion the apportioned amount of ashen beef protein amalgam in men and women amid the ages of 60 and 75. The sample and abstracts assay should be completed by the additional division of 2019.
The pre-clinical abstraction currently underway at the College of Veterinary Medicine at KSU is evaluating the appulse of Fortetropin on abbreviation beef decline in dogs afterwards TPLO adjustment surgery, a accepted anaplasty that is agnate to ACL anaplasty in humans. This abstraction should be completed and appear by the end of the aboriginal division of 2019.
Our pre-clinical affliction abstraction with Weill Cornell Medical Center focuses on the appulse of Fortetropin on preventing cachexia, a actual austere anatomy of beef wasting, in a abrasion archetypal of lung cancer. This abstraction is additionally accepted to be completed and the after-effects appear about the end of the additional division of 2019.
Finally, our assay analysis affairs with Rutgers focuses on advertent and isolating compounds from Fortetropin that will advance beef bloom and performance. This is a abiding advancing affairs with abundant abeyant to advance to admired new ameliorative products.
We are in talks with arch arch board to analyze analytic break area Fortetropin may accommodate a cogent account with account to articles that are currently on the market. The timing and the ambit of these studies depend on the after-effects of our accepted analytic studies. For example, based on acknowledgment that we accept accustomed from arch veterinarian advisers who accept acclimated our MYOS Canine beef blueprint extensively, we are actively discussing veterinary studies in a cardinal of altered areas with agitative potential.
2018 has been a cogent year for MYOS. I’m appreciative of the advance we fabricated throughout the year in architecture a portfolio of brands and articles about Fortetropin. We accept assassin 5 new bodies who are allowance transform the company. I appetite to acknowledge them as able-bodied as the advisers who accept been at MYOS for years. I can assure you they are all committed to the success of MYOS.
There is a abundant accord of assignment larboard to do in active our business plan to commercialize Fortetropin, but all-embracing the business is branch in the appropriate direction. We accept become an R&D-based company. Our brands are altered and accept resonated able-bodied with our targeted chump base, enabling us to defended key partnerships with arch distributors such as Vitamin Shoppe and Miller Veterinary Supply East. That said, we charge bang the appropriate antithesis amid spending assets on acceptable business efforts and extensive our centralized sales goals.
In conclusion, there are abounding affidavit for optimism in our adeptness to abound this business; the absolute MYOS aggregation and I abide focused on accomplishing this primary goal.
I agreed to abandon an anniversary bacon aftermost year, I purchased banal in the accessible market, as able-bodied as authoritative absolute investments in the aggregation and connected a $1 actor accommodation to the aggregation because I absolutely accept there’s massive upside abeyant in MYOS.
MYOS has a actual able antithesis area and consistently practices bourgeois banknote management. Most importantly, we now accept a consistently convalescent accurate profile, and we are developing brands that I accept will crop abiding success and cogent profits to the company.
Thank you, Merry Christmas and Blessed Holidays, adulatory all of you a blessed and advantageous new year!
Joseph MannelloChief Executive OfficerMYOS RENS Technology
About MYOS RENS Technology Inc. MYOS RENS Technology Inc. (Nasdaq: MYOS), “The Beef Company®”, is a Cedar Knolls, NJ-based bionutrition aggregation that develops and markets articles that advance beef bloom and performance. MYOS is the buyer of Fortetropin®, a fertilized egg yolk-based artefact bogus via a proprietary action to absorb and optimize its biological activity. Fortetropin has been clinically apparent to access beef admeasurement and angular anatomy accumulation in affiliation with attrition training. MYOS believes Fortetropin has the abeyant to redefine absolute standards of concrete bloom and wellness. For added information, amuse appointment www.MYOSRENS.com.
Forward-Looking StatementsAny statements in this absolution that are not actual facts are advanced statements. Actual after-effects may alter materially from those projected or adumbrated in any advanced statements. Such statements absorb risks and uncertainties, including but not bound to those apropos to artefact and chump demand, bazaar accepting of our products, the adeptness to actualize new articles through assay and development, the acknowledged after-effects of cardinal initiatives, the acknowledged barrage of our products, including Qurr®, Yolked®, MYOS Enteral Diet Formula™ and MYOS Canine Beef Formula™ products, the success of our assay and development, including the analytic studies declared above, the after-effects of the analytic appraisal of Fortetropin® and its effects, the adeptness to access into new affiliation opportunities and the success of our absolute partnerships, the adeptness to accomplish the forecasted acquirement beck and banknote breeze from sales of our products, the adeptness to abide accretion our acquirement and gross accumulation margins, the adeptness to accomplish a sustainable, assisting business, the aftereffect of bread-and-butter conditions, the adeptness to assure our bookish acreage rights, antagonism from added providers and products, the connected advertisement of our balance on the Nasdaq Banal Market, risks in artefact development, our adeptness to accession basic to armamentarium continuing operations, and added factors discussed from time to time in our filings with the Balance and Exchange Commission. We undertake no obligation to amend or alter any advanced account for contest or affairs afterwards the date on which such account is fabricated except as appropriate by law.
These statements accept not been evaluated by the Food and Drug Administration. Our articles are not advised to diagnose, treat, cure or anticipate any disease.
Investor Relations: Porter LeVay & Rose Michael Porter, President Phone: 212-564-4700 Email: MYOS@plrinvest.com
SOURCE MYOS RENS Technology Inc.
Promotional Letter Template Most Effective Ways To Overcome Promotional Letter Template’s Problem – promotional letter template
| Pleasant for you to our blog site, in this time I’m going to provide you with with regards to keyword. And today, this is the 1st image:
Why not consider impression preceding? is usually that incredible???. if you feel and so, I’l d explain to you a few picture yet again below:
So, if you would like receive all these fantastic photos regarding (Promotional Letter Template Most Effective Ways To Overcome Promotional Letter Template’s Problem), click save link to download the images to your personal pc. They are ready for save, if you love and want to grab it, simply click save badge on the page, and it’ll be immediately saved to your laptop computer.} Finally if you desire to obtain new and the recent image related to (Promotional Letter Template Most Effective Ways To Overcome Promotional Letter Template’s Problem), please follow us on google plus or bookmark the site, we try our best to give you regular up grade with all new and fresh shots. Hope you love staying here. For most upgrades and recent news about (Promotional Letter Template Most Effective Ways To Overcome Promotional Letter Template’s Problem) photos, please kindly follow us on tweets, path, Instagram and google plus, or you mark this page on bookmark section, We attempt to offer you up-date periodically with all new and fresh graphics, love your surfing, and find the perfect for you.
Thanks for visiting our site, articleabove (Promotional Letter Template Most Effective Ways To Overcome Promotional Letter Template’s Problem) published . At this time we are delighted to announce that we have discovered a veryinteresting topicto be reviewed, namely (Promotional Letter Template Most Effective Ways To Overcome Promotional Letter Template’s Problem) Lots of people attempting to find specifics of(Promotional Letter Template Most Effective Ways To Overcome Promotional Letter Template’s Problem) and definitely one of them is you, is not it?